Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome
NCT00565526 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28
Last updated 2018-07-05
Summary
Background:
Sj(SqrRoot)(Delta)gren s Syndrome (SS) is an autoimmune disease that affects the glands that produce saliva and tears, causing dry eyes and dry mouth.
Researchers do not know the exact cause of SS, but they believe that it may be caused by abnormalities in the autonomic nervous system (ANS) that stimulate these glands.
Objectives:
To better understand ANS function in patients with SS.
To compare information about ANS function in healthy individuals and in patients with SS.
Eligibility:
Patients with Sj(SqrRoot)(Delta)gren s Syndrome who are 18 years of age and older, and who are not pregnant or breastfeeding.
Participants will be asked to taper or discontinue the use of certain medications or dietary supplements before the ANS testing.
Participants must be willing to discontinue the use of alcohol and tobacco 24 hours prior to testing.
Design:
The study will require one inpatient admission and/or outpatient visits to the NIH Clinical Center.
The following tests and procedures will be performed:
* Saliva, tear, and sweat production measurements to evaluate the function of glands.
* Testing of changes to the cardiovascular system, including blood pressure and blood flow testing, and an electrocardiogram designed to evaluate hemodynamic changes controlled by the ANS.
* Testing of changes to the gastrointestinal system, including a swallowing assessment study, barium swallow study, and gastric emptying study designed to evaluate gastrointestinal function controlled by the ANS.
* Tests to evaluate the ANS function in response to certain drugs (edrophonium, glucagon and acetylcholine).
* Self-reported questionnaire on ANS function and emotional/psychological well-being.
Additional procedures and tests may include the following:
* Blood samples.
* Optional skin biopsy to study sweat glands and nerve supply of the skin.
Conditions
- Sjogren's Syndrome
- Dysautonomia
Sponsors & Collaborators
-
National Institute of Dental and Craniofacial Research (NIDCR)
lead NIH
Principal Investigators
-
Stamatina J Danielides, M.D. · National Institute of Dental and Craniofacial Research (NIDCR)
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-11-26
- Completion
- 2014-04-10
Countries
- United States
Study Locations
More Related Trials
-
Functional Analysis of Salivary Glands and Correlation With Sialoscintigraphy in Sjogren's Syndrome
NCT06536075 ·Status: RECRUITING ·Phase: NA
-
Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
NCT02112019 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Salivary Gland Dysfunction
NCT00001196 ·Status: TERMINATED
-
Effects of Acupuncture on Sjögren's Syndrome
NCT04056221 ·Status: COMPLETED ·Phase: NA
-
Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease
NCT06805448 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Oral Bacteria in Patients With Dry Mouth
NCT00048685 ·Status: COMPLETED
-
HRR as a Novel Biomarker in Sjögren's Syndrome
NCT05633524 ·Status: COMPLETED
-
Hydroxychloroquine Blood Levels in Primary Sjögren Syndrome Patients
NCT04546542 ·Status: COMPLETED
-
Dental and Periodontal Status of Patients With Sjögren's Syndrome.
NCT04848870 ·Status: RECRUITING
-
Histopathological Analysis Versus Full-field Optical Coherence Tomography of Minor Salivary Gland Biopsy in Suspect Sjogren Syndrome
NCT06454370 ·Status: RECRUITING
-
The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome
NCT05680064 ·Status: COMPLETED ·Phase: NA
-
Olfactory and Taste Disturbances in Sjogren's Syndrome
NCT04909112 ·Status: UNKNOWN ·Phase: NA
-
Salivary Evaluation in Healthy Volunteers
NCT00001390 ·Status: COMPLETED
-
Quality of Life and Sjögren Syndrome
NCT03578900 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome
NCT03711214 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Role of Central Sensitization on Biopsychosocial Factors in Primary Sjögren's Syndrome
NCT06410742 ·Status: COMPLETED
-
An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness
NCT01369589 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease
NCT04212572 ·Status: UNKNOWN
-
Characterization of Diseases With Salivary Gland Involvement
NCT02327884 ·Status: RECRUITING
-
Salivary Markers in Patients With Xerostomia
NCT03156569 ·Status: COMPLETED
-
Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.
NCT05124925 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Potential Effect of Innovative Cell-based Therapy Using Adipose-derived Stromal Vascular Fraction in Patients With Autoimmune Xerostomia
NCT05857358 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Diagnostic Interest of the Buccal Schirmer Test in Xerostomia During Sjögren's Syndrome: XERODIAG
NCT06530940 ·Status: NOT_YET_RECRUITING
-
Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome
NCT02066896 ·Status: COMPLETED ·Phase: NA
-
Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome
NCT00637793 ·Status: COMPLETED ·Phase: PHASE2